NDC 68504-001 - ESTROPLAN

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 68504-001
Package NDCs from labels: 68504-001-01, 68504-001-02
Manufacturer: Parnell Technologies Pty Ltd | Parnell Manufacturing Pty Ltd
Effective date: 2024-05-15
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
ESTROPLAN - Parnell Technologies Pty Ltd \| Parnell Manufacturing Pty Ltd	Parnell Technologies Pty Ltd \| Parnell Manufacturing Pty Ltd	2024-05-15	PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68504-001-01	ESTROPLAN	20 mL in 1 VIAL, MULTI-DOSE	INJECTION, SOLUTION	20	9
68504-001-01	ESTROPLAN	1 in 1 CARTON	INJECTION, SOLUTION	1	9
68504-001-02	ESTROPLAN	1 in 1 CARTON	INJECTION, SOLUTION	1	9
68504-001-02	ESTROPLAN	100 mL in 1 VIAL, MULTI-DOSE	INJECTION, SOLUTION	100	9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68504-001	ESTROPLAN (CLOPROSTENOL SODIUM) INJECTION, SOLUTION [PARNELL TECHNOLOGIES PTY LTD]	9	4 package rows	20240517_1b3ce6fb-0493-4b22-ab53-d2d52af47267.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
cloprostenol sodium	ACTIVE INGREDIENT	886SAV9675	ESTROPLAN (CLOPROSTENOL SODIUM) INJECTION, SOLUTION [PARNELL TECHNOLOGIES PTY LTD]	3
cloprostenol	ACTIVE MOIETY	4208238832	ESTROPLAN (CLOPROSTENOL SODIUM) INJECTION, SOLUTION [PARNELL TECHNOLOGIES PTY LTD]	3
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	ESTROPLAN (CLOPROSTENOL SODIUM) INJECTION, SOLUTION [PARNELL TECHNOLOGIES PTY LTD]	3
CHLOROCRESOL	INACTIVE INGREDIENT	36W53O7109	ESTROPLAN (CLOPROSTENOL SODIUM) INJECTION, SOLUTION [PARNELL TECHNOLOGIES PTY LTD]	3
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	ESTROPLAN (CLOPROSTENOL SODIUM) INJECTION, SOLUTION [PARNELL TECHNOLOGIES PTY LTD]	3
sodium citrate	INACTIVE INGREDIENT	1Q73Q2JULR	ESTROPLAN (CLOPROSTENOL SODIUM) INJECTION, SOLUTION [PARNELL TECHNOLOGIES PTY LTD]	3

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 47 of 47 · 921 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lactated Ringers	SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	Baxter Healthcare Corporation	f09f80bf-2f8b-4420-865d-aec2d5e5cd4d	2012-06-12		Exact identifier unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.